The earliest realistic timeline for UK availability is 2028 or later, following anticipated phase 3 data in 20252026, a potential MHRA submission in 20262027, and subsequent NICE appraisal
For decades, the prevailing medical theory for widespread pain in ME/CFS and fibromyalgia was "central sensitization." This theory posited that the central nervous system (the brain and spinal cord) had become hyper-reactive, amplifying normal sensory input into severe pain
Muscle Defense: Access workout tips and videos to help protect and maintain your muscle mass while losing weight
Topical vs Injectable: Which Is Better
Comparing MEDVi to Other Providers: Why This Platform Stands Out The Crowded GLP-1 Market: More Options, More Confusion The surge in popularity of GLP-1 medications like Semaglutide and Tirzepatide has led to a flood of online weight loss programs, telehealth clinics, and supplement startups
Animal Studies: Strong Results in Obese Rodent Models The foundational animal work was conducted in obese Zucker rats and ob/ob mice, two standard models for studying obesity